Bharat Biotech

World’s first intra-nasal vaccine for COVID developed by India approved for restricted use in emergency situations
Health Ministry denies media reports on rushed regulatory approval for Covaxin due to political pressure
WHO issues emergency use listing for Covaxin, India's COVID-19 vaccine
DCGI approves Phase II/III clinical trial of Covaxin in age group of 2-18 years
Bharat Biotech announces Phase 3 Results of Covaxin
Don't deserve this backlash, says Covaxin maker Bharat Biotech
DGCI approves Serum Institute, Bharat Biotech COVID-19 vaccines for restricted emergency use
After 'Covishield', expert panel recommends Bharat Biotech's 'Covaxin' for emergency use
No vaccine approval yet, drug regulator analysing SII, Bharat Biotech data
Modi visits COVID-19 vaccine facilities in three cities, discusses ways of improving distribution
Modi to visit vaccine facilities in Ahmedabad, Hyderabad, Pune on Saturday
logo
NetIndian
www.netindian.in